Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ADH6 |
| Upstream (Parents) |
|---|
| (<<) UGT2B28 → ADH6 |
| (<<) GATM → ADH6 |
| Downstream (Children) |
|---|
| ADH6 → SLC38A4 (>>) |
| ADH6 → ABCG5 (>>) |
| ADH6 → FGFR3 (>>) |
| ADH6 → UGT1A3///UGT1A1///UGT1A4///UGT1A9///UGT1A5///UGT1A6///UGT1A7///UGT1A8///UGT1A10 (>>) |
| ADH6 → UGT1A9///UGT1A6///UGT1A8 (>>) |
| ADH6 → GBA3 (>>) |
| ADH6 → A1CF (>>) |
| ADH6 → UGT1A1///UGT1A4///UGT1A9///UGT1A6///UGT1A8///UGT1A10 (>>) |
| ADH6 → HGD (>>) |
| ADH6 → DCXR (>>) |
| ADH6 → ALDH1A1 (>>) |
| ADH6 → CDH19 (>>) |
| ADH6 → SLC17A4 (>>) |
| ADH6 → ENTPD5 (>>) |
| ADH6 → NAT2 (>>) |
| ADH6 → SLC27A2 (>>) |
| ADH6 → PBLD (>>) |
